TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
25.71
+1.36 (5.59%)
At close: Oct 29, 2024, 4:00 PM
25.50
-0.21 (-0.82%)
After-hours: Oct 29, 2024, 7:25 PM EDT

TG Therapeutics Revenue

TG Therapeutics had revenue of $73.47M in the quarter ending June 30, 2024, with 357.05% growth. This brings the company's revenue in the last twelve months to $346.72M, up 1,341.56% year-over-year. In the year 2023, TG Therapeutics had annual revenue of $233.66M with 8,290.02% growth.

Revenue (ttm)
$346.72M
Revenue Growth
+1,341.56%
P/S Ratio
10.69
Revenue / Employee
$1,313,348
Employees
264
Market Cap
3.69B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023233.66M230.88M8,290.02%
Dec 31, 20222.79M-3.90M-58.36%
Dec 31, 20216.69M6.54M4,300.66%
Dec 31, 2020152.00K--
Dec 31, 2019152.00K--
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Perrigo Company 4.43B
Envista Holdings 2.53B
Amedisys 2.29B
Apellis Pharmaceuticals 628.79M
HUTCHMED (China) 610.81M
Amicus Therapeutics 455.66M
Axonics 408.81M
PROCEPT BioRobotics 176.58M
Revenue Rankings